Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Higher Death Rate Forces Bayer to Stop Xofigo/Zytiga Combo Late-Stage Study Early

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

An IDMC told Bayer that it should unblind its Phase III clinical trial in prostate cancer in order to further analyze an increased number of fractures and deaths. Source: BioSpace

Continue ReadingHigher Death Rate Forces Bayer to Stop Xofigo/Zytiga Combo Late-Stage Study Early

3 Biotechs to Load Up on This Holiday Season

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:BioPharma

These great biotech stocks to buy for the holidays come in all sizes -- small-cap, mid-cap, and large-cap. Source: BioSpace

Continue Reading3 Biotechs to Load Up on This Holiday Season

3 Big Pharmas That Could be Winners for Investors in the Long Run

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

Big pharma stocks have been longtime favorites among investors for several reasons. Source: BioSpace

Continue Reading3 Big Pharmas That Could be Winners for Investors in the Long Run

Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

The round was co-led by Eight Roads Ventures and Cowen Healthcare Investments. Source: BioSpace

Continue ReadingCambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest

Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

Genmab just received a $20M milestone payment from Janssen Biotech. Source: BioSpace

Continue ReadingGenmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation

Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

Sanofi's setback could open the door for rival drugmaker Takeda. Source: BioSpace

Continue ReadingSanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow

Boston's Anti-Aging Startup resTORbio Scores $40M

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

This financing brings the total capital raised this year to $65 million, including a $25 million Series A financing that was completed earlier this year. Source: BioSpace

Continue ReadingBoston's Anti-Aging Startup resTORbio Scores $40M

Sexual Harassment Scandals Hit Novartis and Pfizer's Korea Units

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

On Wednesday, KBR reported that a male employee at Novartis Korea reported to the company that his female boss sexually harassed him in September. Source: BioSpace

Continue ReadingSexual Harassment Scandals Hit Novartis and Pfizer's Korea Units

3 Bioeconomy Stocks Investors Should Not Hesitate to Buy

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

While the words biotech and biopharma are often used interchangeably, they aren't the same thing - not even close, in fact. Source: BioSpace

Continue Reading3 Bioeconomy Stocks Investors Should Not Hesitate to Buy

Mettler-Toledo to Begin Layoffs in March, 69 Employees Affected

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

Mettler-Toledo will begin to issue pink slips in March to employees at an upstate New York manufacturing facility. Source: BioSpace

Continue ReadingMettler-Toledo to Begin Layoffs in March, 69 Employees Affected
  • Go to the previous page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.